a once a day anti-rejection medicine for kidney transplant patients
Just once a day ENVARSUS XR is a form of the anti-rejection drug, tacrolimus, for people who have had a kidney transplant. Doctors have depended on tacrolimus to help prevent rejection for about 20 years; it is the most commonly used anti-rejection medicine (also called an immunosuppressant) in the US.
Designed to deliver tacrolimus more smoothly over the whole day
If your doctor prescribed ENVARSUS XR, you will be switching from another form of tacrolimus. ENVARSUS XR is an extended-release tablet that is taken just once a day in the morning.